Mon, May 15, 2023
Fri, May 12, 2023
Thu, May 11, 2023

David Nierengarten Reiterated (ANAB) at Hold and Held Target at $29 on, May 12th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-29-on-may-12th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Nierengarten of Wedbush, Reiterated "AnaptysBio, Inc." (ANAB) at Hold and Held Target at $29 on, May 12th, 2023.

David has made no other calls on ANAB in the last 4 months.



There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Anupam Rama of "JP Morgan" Maintained at Sell with Decreased Target to $31 on, Wednesday, April 12th, 2023

Publication Contributing Sources